Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: In this session 116 PD of the New York Annual Meeting the panel discusses factors which led to the development of alternative risk transfer transactions in the property and casualty markets, and review techniques used to transfer and trade insurance risks within the capital markets. From the Record of the Society of Actuaries, Vol. 24, No. 3.

Description: When annuity products became prevalent in the U.S., they all looked more or less the same. It was where folks put their safe retirement money, yielding modest guaranteed returns with a menu of payout options to help secure their retirement. Over time, this commoditization lead to a pricing squeeze and an exhaustive set of product options and features, exposing carriers to market and policyholder behavior risk over the past decade or so.

Description: This session from the 1983 SOA Vancouver Meeting reviews the Business Mens Assurance's computerized mortality study on its reinsured business. It also discusses smoker/non-smoker mortality assumptions, surplus relief via traditional coinsurance and mod-co and TEFRA impact on reinsurance. From Record of Society of Actuaries Vol. 9, No. 3

Description: In this session 50SM of the Montreal Spring Meeting panelists review the results of recent tax court cases that will have an impact on the tax treatment of reinsurance agreements. From the Record of the Society of Actuaries, Vol. 23, No. 2.

Description: This presentation is a panel discussion, session 55PD, from the 2004 Spring Meeting of the Society of Actuaries, held June 14-15 in San Antonio, TX. Low new money rates, new reserve requirements and the limited availability of reinsurance solutions have highlighted the risks associated with offering UL secondary guarantees. The panelists discuss the types of risks and emerging practices in risk assessment and pricing of UL secondary guarantees, the current UL market, recent developments in product, and pricing techniques. Discussion from participants is included. From the Record of Society of Actuaries, Volume 30, No. 2.

Description: This session at the SOA 1990 Annual Meeting examines the possible state of the reinsurance marketplace in the year 2000. Focus is on the purpose and role of reinsurance in the future, globalization, and the role of the actuary.

Description: Panelists discuss Lloyd's of London, its past difficulties, and its future role in the reinsurance market. From the Record of the Society of Actuaries, Vol. 23, No. 1.

Description: Panelists discuss many developments over the year 1992 that impact the valuation actuary. Session 1 of the 1992 Valuation Actuary Symposium.

Description: In session 133 PD of the New York Annual Meeting panelists explore the impact of pricing products from the perspective of the direct writing company and their reinsurer. From the Record of the Society of Actuaries, Vol. 24, No. 3.